Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-29

Clinical Trial Update: Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy [NA]

View source ↗

Summary

This clinical trial explores how rare gene mutations influence atypical hemolytic uremic syndrome and aims to inform personalized treatment approaches.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Atypical Hemolytic Uremic Syndrome | NA | Status: RECRUITING